Accordingly, we observed a highly significant correlation between GREB1 and MYO1B mRNA expression across five different NB tumor cohorts (Fig. 2F), as well as in multiple prostate adenocarcinoma cohorts in public datasets (fig. This evidence concerns the gene MYO1B and neoplasm.